A detailed history of Walleye Capital LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 25,400 shares of ZTS stock, worth $4.49 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,400
Previous 37,400 32.09%
Holding current value
$4.49 Million
Previous $6.48 Million 23.46%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$172.58 - $196.48 $13.1 Million - $14.9 Million
75,964 Added 73.24%
179,685 $35.1 Million
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $13.3 Million - $16.3 Million
91,121 Added 723.18%
103,721 $18 Million
Q1 2024

May 15, 2024

SELL
$165.67 - $199.94 $8.52 Million - $10.3 Million
-51,403 Reduced 80.31%
12,600 $2.13 Million
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $3.57 Million - $4.72 Million
23,585 Added 58.35%
64,003 $12.6 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $6.76 Million - $7.79 Million
40,418 New
40,418 $7.03 Million
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $31,423 - $37,804
216 New
216 $35,000
Q2 2022

Aug 08, 2022

BUY
$155.97 - $200.09 $1.93 Million - $2.48 Million
12,391 Added 523.49%
14,758 $2.54 Million
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $429,350 - $553,949
2,367 New
2,367 $446,000
Q4 2021

Mar 03, 2022

SELL
$193.69 - $247.03 $1.02 Million - $1.3 Million
-5,269 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $862,973 - $955,976
4,559 Added 642.11%
5,269 $1.02 Million
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $6,975 - $7,995
-60 Reduced 7.79%
710 $94,000
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $73,170 - $83,479
650 Added 541.67%
770 $96,000
Q1 2019

May 15, 2019

BUY
$81.56 - $100.67 $9,787 - $12,080
120 New
120 $12,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.